Experimental and Molecular Medicine (Jan 2019)

MiR-34a and miR-34b/c have distinct effects on the suppression of lung adenocarcinomas

  • Jeong Seon Kim,
  • Eun Ju Kim,
  • Sieun Lee,
  • Xiaochao Tan,
  • Xin Liu,
  • Sanghui Park,
  • Keunsoo Kang,
  • Jung-Sook Yoon,
  • Yoon Ho Ko,
  • Jonathan M. Kurie,
  • Young-Ho Ahn

DOI
https://doi.org/10.1038/s12276-018-0203-1
Journal volume & issue
Vol. 51, no. 1
pp. 1 – 10

Abstract

Read online

Cancer: Regulatory micro-RNAs could combine for treatment Exploring the effects of three similar small RNA molecules called micro-RNAs (miRNAs) that can restrict the activity of specific genes reveals how they might be used in cancer treatment. RNA is best known as messenger RNA, which carries a copy of a gene’s information into the cell cytoplasm to direct protein manufacture. Many small RNAs play less well-known but crucial roles by binding to messenger RNA molecules to regulate their activity. Researchers in South Korea and USA, led by Young-Ho Ahn at Ewha Womans University in Seoul, investigated how these miRNAs can suppress lung cancer in mice. Their results reveal details of how the miRNAs inhibit the expression of specific tumor-supporting genes. They suggest that three of the RNAs administered together might treat cancer more effectively than using only one as in previous trials.